The Latest Breaking News from EMA

The biotechnology industry is booming thanks to growing demand for innovative healthcare solutions, favorable government initiatives, and several scientific breakthroughs. Thus, quality biotech stocks Genmab (GMAB), Halozyme Therapeutics (HALO), and Vertex Pharmaceuticals (VRTX) could be ideal buys for substantial profits. Read more….

Growing medical needs, surging demand for precision medicine, favorable regulatory climate, and rapid digital transformation would create promising growth opportunities for pharma companies. Hence, it could be wise to invest in top pharma stocks Johnson & Johnson (JNJ), Spero Therapeutics (SPRO), Ipsen (IPSEY), and Procaps Group (PROC) for solid gains.…

Shahin and Morris Schuring will pair up with Manthey’s designated Pro driver Richard Lietz at the wheel of the #91 Porsche 911 GT3 R (Type 992) that will be run in collaboration with EMA in the new LMGT3 class.

Amid a growing remote workforce, IT teams are challenged to provide a smooth Wi-Fi experience.

Hold onto your hats, folks, because there's some fascinating news in the world of diabetes and obesity drugs! A recent federal study found that people taki...

Thomas Preining had already marked himself out as a future champion during his rookie DTM season in 2022 with the single-car Team Bernhard operation. So it shouldn’t come as a surprise that he delivered on that promise in his sophomore campaign this year after being given a plum seat at…

To overcome problematic opioid use, traditional forms of opioid substitution therapy, such as methadone and oral buprenorphine, have become valuable tools. Research shows that patients receiving substitution therapy are more likely to stay in treatment and stop using heroin than patients receiving treatments that do not involve substitutes – such…

We need to address the unnecessary and wasteful Medsafe approval for tried and tested drugs by much bigger regulatory authorities abroad, argues Dr Eric Crampton

Austria’s criminal investigation service warned on Monday that fake injection pens may still be in circulation

The pharma industry’s prospects look bright, thanks to rising demand for generic and innovative drugs and technological advancements. Hence, adding fundamentally strong pharma stocks Astellas Pharma (ALPMY), Sanofi (SNY), and GSK (GSK) to one’s watchlist could be wise. Keep reading.

Blending modern flavors and traditional dishes can be tricky. Follow chef CJ Jacobson's advice to pull it off